Bio-Pharm Archives - 17 중 12 번째 페이지

SK bioscience's Influenza Vaccine ‘SkyCellflu’ Approved in Indonesia

SK bioscience announced that its quadrivalent cell-culture influenza vaccine, SkyCellflu Quadrivalent Pre-filled Syringe(SkyCellflu), has obtained final market authorization from the Indonesian National Agency of Drug and Food Control (BPOM). This…

Cheon Okhyeon

2024-10-23

Samsung Biologics Secures Record 1.7 Trillion KRW Contract

Samsung Biologics has made headlines again. On the 22nd, the company announced that it had signed a massive Contract Manufacturing Organization (CMO) deal worth 1.7028 trillion KRW ($1.24 billion) with…

Cheon Okhyeon

2024-10-22

Bukwang's Performance Declines Over 2.5 Years Under OCI: Will Q3 Bring a Turnaround?

It's been two and a half years since OCI became the largest shareholder of Bukwang Pharmaceutical, yet instead of generating synergy, Bukwang's financial performance has continued to falter. On the…

Cheon Okhyeon

2024-10-21

Will GE Healthcare’s ‘Omnipaque’ Contribute to Early Breast Cancer Detection in Korea?

Contrast-enhanced mammography (CEM) is gaining attention as a crucial method in the fight against breast cancer, the most common cancer among Korean women. At a press conference hosted by GE…

Jang Jawon

2024-10-17

DongKook Pharm Acquires ODM Company ReBom Cosmetics

DongKook Pharmaceutical strengthens its cosmetics business by acquiring ReBom Cosmetics. On the 16th, DongKook Pharmaceutical announced that it had signed a contract to acquire ReBom Cosmetics, a company specializing in…

Cheon Okhyeon

2024-10-16

STGen Bio Secures FDA cGMP Approval for Songdo Bio Plant

STGen Bio announced on the 14th that its Songdo Bio Plant has received current Good Manufacturing Practice (cGMP) approval from the U.S. Food and Drug Administration (FDA). The approval covers…

Jang Jawon

2024-10-14

Hugel Wins Botulinum Toxin Lawsuit Against Medytox

Hugel has won the final ruling in the botulinum toxin-related lawsuit it faced against Medytox in the United States International Trade Commission (ITC). The ruling clears Hugel of allegations that…

Cheon Okhyeon

2024-10-11

Liga-Chem Licenses ADC Technology to Japan’s Ono Pharmaceutical in USD 700M Deal

Liga-Chem Biosciences announced on the 10th that it had signed two licensing agreements with Ono Pharmaceutical, a leading pharmaceutical company in Japan. The pipeline that Liga-Chem Biosciences transferred includes "LCB97,"…

Jang Jawon

2024-10-10

Orum Therapeutics Sets Goal of USD 70 Million by 2026

Orum Therapeutics, a biotechnology company preparing for its KOSDAQ listing, announced its goal to achieve sales of KRW 93 billion (USD 69.9 million) by 2026. In a media conference call…

Jang Jawon

2024-10-08

"Samsung Biologics Poised for Growth with Plant 5 and Biosecurity Law"

There is an evaluation that Samsung Biologics' stock could rise in the short term if the U.S. Biosecurity Law is passed. On the 7th, Kim Jun-young of Meritz Securities stated,…

Cheon Okhyeon

2024-10-07